Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free KALV Stock Alerts

KalVista Pharmaceuticals (KALV) Institutional Ownership

KalVista Pharmaceuticals logo
$26.71 +0.05 (+0.19%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$26.66 -0.05 (-0.18%)
As of 05/5/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for KalVista Pharmaceuticals (NASDAQ:KALV)

Number of
Institutional Buyers
(last 12 months)
94
Total
Institutional Inflows
(last 12 months)
$239.80M
Number of
Institutional Sellers
(last 12 months)
51
Total
Institutional Outflows
(last 12 months)
$131.57M
Get KALV Insider Trade Alerts

Want to know when executives and insiders are buying or selling KalVista Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KALV Institutional Buying and Selling by Quarter

KalVista Pharmaceuticals Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/5/2026Bank of New York Mellon Corp584,347$11.76M0.0%-15.9%1.141%
5/4/2026 Emerald Mutual Fund Advisers Trust805,762$16.22M0.8%-5.8%1.573%
5/4/2026 Emerald Advisers LLC1,264,023$25.45M0.8%-5.7%2.468%
5/4/2026 Bleakley Financial Group LLC12,954$261K0.0%-18.9%0.025%
4/27/2026 Y Intercept Hong Kong Ltd33,776$680K0.0%N/A0.066%
4/16/2026 SG Americas Securities LLC21,828$439K0.0%-54.6%0.043%
2/26/2026Seven Fleet Capital Management LP48,412$782K0.6%N/A0.096%
2/19/2026Invesco Ltd.77,864$1.26M0.0%+23.1%0.154%
2/18/2026XTX Topco Ltd26,508$428K0.0%N/A0.052%
2/18/2026Ikarian Capital LLC35,119$567K0.0%-91.2%0.069%
2/18/2026Vestal Point Capital LP1,890,000$30.52M1.0%+152.0%3.739%
2/18/2026Virtus Investment Advisers LLC40,414$653K0.2%+364.9%0.080%
2/18/2026Wellington Management Group LLP122,379$1.98M0.0%-2.9%0.242%
2/18/2026Squadron Capital Management LLC700,000$11.31M4.8%N/A1.385%
2/18/2026Tang Capital Management LLC4,573,530$73.86M3.6%-9.3%9.048%
2/18/2026Orbimed Advisors LLC382,400$6.18M0.1%N/A0.757%
2/18/2026Man Group plc17,446$282K0.0%N/A0.035%
2/18/2026Elmind Capital LP801,300$12.94M3.8%N/A1.585%
2/18/2026Caption Management LLC117,907$1.90M0.0%-183.3%0.233%
2/18/2026Armistice Capital LLC800,000$12.92M0.2%N/A1.583%
2/17/2026Freestone Grove Partners LP633,019$10.22M0.1%-10.1%1.252%
2/17/2026Schonfeld Strategic Advisors LLC305,880$4.94M0.0%-31.5%0.605%
2/17/2026AQR Capital Management LLC24,666$398K0.0%-44.7%0.049%
2/17/2026Jump Financial LLC90,742$1.47M0.0%N/A0.180%
2/17/2026Price T Rowe Associates Inc. MD23,118$374K0.0%+15.7%0.046%
2/17/2026Osaic Holdings Inc.21,937$354K0.0%-6.1%0.043%
2/17/2026California State Teachers Retirement System28,410$459K0.0%+16.5%0.056%
2/17/2026Atom Investors LP276,113$4.46M0.4%N/A0.546%
2/17/2026State of Wisconsin Investment Board15,923$257K0.0%-75.9%0.031%
2/17/2026ExodusPoint Capital Management LP20,061$324K0.0%N/A0.040%
2/17/2026Magnetar Financial LLC10,938$177K0.0%-59.4%0.022%
2/16/2026Spruce Street Capital LP387,968$6.27M2.1%N/A0.767%
2/16/2026Truvestments Capital LLC4,684$76K0.0%+253.8%0.009%
2/16/2026Panagora Asset Management Inc.109,391$1.77M0.0%-44.6%0.216%
2/16/2026NEXTBio Capital Management LP131,796$2.13M1.2%N/A0.261%
2/16/2026Barclays PLC700,573$11.31M0.0%+21.2%1.386%
2/13/2026The Manufacturers Life Insurance Company 11,823$191K0.0%-11.0%0.023%
2/13/2026Schroder Investment Management Group1,171,755$18.92M0.0%+1.1%2.318%
2/13/2026Rafferty Asset Management LLC65,593$1.06M0.0%+13.5%0.130%
2/13/2026Birchview Capital LP57,000$921K0.5%-14.9%0.113%
2/13/2026Charles Schwab Investment Management Inc.324,369$5.24M0.0%+0.7%0.642%
2/13/2026State Street Corp1,911,691$30.87M0.0%+21.3%3.782%
2/13/2026Martingale Asset Management L P30,939$500K0.0%N/A0.061%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC27,722$448K0.0%+103.8%0.055%
2/13/2026Wells Fargo & Company MN56,014$905K0.0%+50.4%0.111%
2/12/2026HRT Financial LP287,052$4.64M0.0%N/A0.568%
2/12/2026Renaissance Technologies LLC165,151$2.67M0.0%N/A0.327%
2/12/2026Skandinaviska Enskilda Banken AB publ 351,305$5.68M0.0%+74.8%0.695%
2/12/2026Alps Advisors Inc.41,504$670K0.0%N/A0.082%
2/12/2026Swiss National Bank54,900$887K0.0%+13.2%0.109%
2/12/2026 Nuveen LLC107,129$1.73M0.0%+34.3%0.212%
2/11/2026Deutsche Bank AG35,091$567K0.0%+16.0%0.069%
2/11/2026Capital World Investors2,808,583$45.36M0.0%-11.6%5.556%
2/10/2026Goldman Sachs Group Inc.835,304$13.49M0.0%-53.6%1.652%
2/9/2026Geode Capital Management LLC944,077$15.25M0.0%+1.7%1.868%
2/9/2026 Bleakley Financial Group LLC15,976$258K0.0%N/A0.032%
2/9/2026Blue Owl Capital Holdings LP360,000$5.81M0.4%+188.0%0.712%
2/6/2026Rathbones Group PLC12,272$198K0.0%-33.4%0.024%
2/3/2026F m Investments LLC236,690$3.82M0.1%+18.8%0.468%
2/2/2026 Cerro Pacific Wealth Advisors LLC10,000$162K0.0%N/A0.020%
1/29/2026UBS Group AG371,993$6.01M0.0%-18.1%0.736%
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank17,868$289K0.0%+293.1%0.035%
1/21/2026Rathbones Group PLC12,272$198K0.0%-33.4%0.024%
1/14/2026Hennion & Walsh Asset Management Inc.341,819$5.52M0.2%+93.6%0.676%
1/9/2026 SG Americas Securities LLC48,030$776K0.0%+15.4%0.095%
1/9/2026 Diversified Trust Co.10,870$176K0.0%N/A0.022%
1/1/2026JPMorgan Chase & Co.20,759$253K0.0%-10.6%0.041%
12/9/2025Tudor Investment Corp ET AL2,000,000$24.36M0.0%N/A3.956%
11/17/2025Vestal Point Capital LP750,000$9.14M0.4%-84.0%1.484%
11/17/2025Susquehanna Fundamental Investments LLC10,686$130K0.0%-63.0%0.021%
11/17/2025Sherbrooke Park Advisers LLC15,678$191K0.1%N/A0.031%
11/17/2025Qube Research & Technologies Ltd325,435$3.96M0.0%+234.6%0.644%
11/17/2025Parkman Healthcare Partners LLC1,735,003$21.13M2.2%+155.5%3.433%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.20,512$250K0.0%-10.7%0.041%
11/17/2025Boxer Capital Management LLC20,400$248K0.1%-78.2%0.040%
11/17/2025Brevan Howard Capital Management LP55,878$681K0.0%+319.1%0.111%
11/17/2025Bank of America Corp DE364,409$4.44M0.0%-0.7%0.721%
11/17/2025Ameriprise Financial Inc.35,449$432K0.0%-96.2%0.070%
11/14/2025Creative Planning38,032$463K0.0%+13.9%0.075%
11/14/2025Schonfeld Strategic Advisors LLC446,372$5.44M0.0%+207.2%0.884%
11/14/2025SummitTX Capital L.P.143,561$1.75M0.1%N/A0.284%
11/14/2025Raymond James Financial Inc.149,306$1.82M0.0%+47.8%0.296%
11/14/2025Freestone Grove Partners LP704,448$8.58M0.1%N/A1.394%
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 4,545$55K0.0%N/A0.009%
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC13,600$166K0.0%N/A0.027%
11/14/2025Suvretta Capital Management LLC4,768,712$58.08M1.5%-3.8%9.439%
11/14/2025F m Investments LLC199,204$2.43M0.1%+9.3%0.394%
11/13/2025Sei Investments Co.11,896$145K0.0%N/A0.024%
11/13/2025UBS Group AG454,148$5.53M0.0%+66.4%0.899%
11/13/2025BNP Paribas Financial Markets7,794$95K0.0%+92.9%0.015%
11/13/2025Magnetar Financial LLC26,924$328K0.0%N/A0.053%
11/13/2025Legal & General Group Plc23,954$292K0.0%+470.1%0.047%
11/13/2025Russell Investments Group Ltd.56,196$684K0.0%+5.9%0.111%
11/13/2025Schroder Investment Management Group1,158,457$14.15M0.0%+108.7%2.293%
11/13/2025Jefferies Financial Group Inc.286,875$3.49M0.0%N/A0.568%
11/13/2025Blue Owl Capital Holdings LP125,000$1.52M0.5%N/A0.247%
11/12/2025Barclays PLC577,904$7.04M0.0%+242.1%1.144%
11/12/2025Dimensional Fund Advisors LP45,444$554K0.0%-73.8%0.090%
11/12/2025Rafferty Asset Management LLC57,790$704K0.0%+23.2%0.114%
11/12/2025Intech Investment Management LLC12,919$157K0.0%-26.9%0.026%


KALV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of KALV shares?

During the previous two years, 159 institutional investors and hedge funds held shares of KalVista Pharmaceuticals. The most heavily invested institutionals were Tang Capital Management LLC ($73.86M), Suvretta Capital Management LLC ($58.08M), Capital World Investors ($45.36M), Frazier Life Sciences Management L.P. ($41.40M), State Street Corp ($30.87M), Vestal Point Capital LP ($30.52M), and Vanguard Group Inc. ($30.46M).Learn more on KalVista Pharmaceuticals' institutional investors.

Which institutional investors have been buying KalVista Pharmaceuticals' stock?

Of the 140 institutional investors that purchased KalVista Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vestal Point Capital LP ($3.61M), Tudor Investment Corp ET AL ($2M), Parkman Healthcare Partners LLC ($1.81M), Stempoint Capital LP ($1.73M), Boxer Capital Management LLC ($1.59M), Capital World Investors ($1.46M), and Octagon Capital Advisors LP ($1.37M).

How much institutional buying is happening at KalVista Pharmaceuticals?

Institutional investors have bought a total of 17,657,831 shares in the last 24 months. This purchase volume represents approximately $239.80M in transactions.

Which of KalVista Pharmaceuticals' major shareholders have been selling company stock?

Of the 51 institutional investors that sold KalVista Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Vestal Point Capital LP ($4.02M), Goldman Sachs Group Inc. ($964.88K), Ameriprise Financial Inc. ($909.68K), Tang Capital Management LLC ($468.27K), JPMorgan Chase & Co. ($384.20K), Capital World Investors ($369.00K), and Ikarian Capital LLC ($364.88K).

How much institutional selling is happening at KalVista Pharmaceuticals?

Institutional investors have sold a total of 9,874,182 shares in the last 24 months. This volume of shares sold represents approximately $131.57M in transactions.


Related Companies

This page (NASDAQ:KALV) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
How to collect $1,170/month from silver
There is a silver fund paying up to 20% in yearly distributions - no mining stocks, no options required. The s...
Investors Alley | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Did you miss The Dark AI Summit?
Over 55,000 people attended Jeff Brown's Dark AI Summit, where he revealed a private AI company he believes ho...
Brownstone Research | Sponsoredtc pixel
Why Elon just bought a power plant (Ticker inside)
Elon Musk is burning nearly $1 billion a month because he cannot power the world's largest supercomputer witho...
Behind the Markets | Sponsoredtc pixel
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next
Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...
Paradigm Press | Sponsoredtc pixel